‘Big Night Out’ Gone Bad: US FDA Says Instagram Post For Merz’s Xeomin Minimizes Risks, Overstates Efficacy

 
• By Sue Sutter

An Office of Prescription Drug Promotion “untitled” letter cites a short-form video by interior designer and TV personality Nate Berkus, continuing an enforcement trend involving drug promotions by social media influencers and celebrities.

Xeomin Instagram post
The FDA's Office of Prescription Drug Promotion found lots to object to in Nate Berkus' Instagram post for Merz Pharma's Xeomin. (Screenshot)

More from Marketing & Advertising

More from Compliance